PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+10.79%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$951M
(+7%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
330
New
34
Increased
99
Reduced
95
Closed
48
Top Buys
| 1 |
McKesson
MCK
|
$137M |
| 2 |
Synopsys
SNPS
|
$134M |
| 3 |
Rambus
RMBS
|
$84M |
| 4 |
NVIDIA
NVDA
|
$84M |
| 5 |
Amazon
AMZN
|
$82.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$110M |
| 2 |
Teradyne
TER
|
$90.7M |
| 3 |
Apple
AAPL
|
$89.1M |
| 4 |
Visa
V
|
$74.5M |
| 5 |
United Therapeutics
UTHR
|
$72.6M |
Sector Composition
| 1 | Technology | 40.96% |
| 2 | Healthcare | 24.28% |
| 3 | Financials | 16.46% |
| 4 | Communication Services | 8.44% |
| 5 | Consumer Discretionary | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Impinj
PI
$5.56B
| $1M | 0.01% |
11,180
-59,424
| -84% | -$5.33M |
|
|
NARI
227
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $908K | ﹤0.01% |
15,610
+7,085
| +83% | +$412K |
|
228
Exact Sciences
EXAS
$10.2B
| $868K | ﹤0.01% |
9,240
+1,630
| +21% | +$153K |
|
229
QuidelOrtho
QDEL
$1.95B
| $860K | ﹤0.01% |
10,375
| – | – |
|
230
AtriCure
ATRC
$1.76B
| $761K | ﹤0.01% |
15,415
| – | – |
|
231
Privia Health
PRVA
$2.86B
| $749K | ﹤0.01% |
28,675
+2,910
| +11% | +$76K |
|
232
Natera
NTRA
$23.1B
| $720K | ﹤0.01% |
14,800
+4,200
| +40% | +$204K |
|
233
iRhythm Technologies
IRTC
$5.82B
| $712K | ﹤0.01% |
6,825
+425
| +7% | +$44.3K |
|
|
FTCH
234
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $698K | ﹤0.01% |
115,553
| – | – |
|
235
NXP Semiconductors
NXPI
$57.2B
| $532K | ﹤0.01% |
2,600
-300
| -10% | -$61.4K |
|
236
Aptiv
APTV
$17.5B
| $510K | ﹤0.01% |
5,000
| – | – |
|
237
Bruker
BRKR
$4.68B
| $442K | ﹤0.01% |
5,975
| – | – |
|
238
SolarEdge
SEDG
$2.04B
| $363K | ﹤0.01% |
1,350
-181,218
| -99% | -$48.8M |
|
239
Visteon
VC
$3.41B
| $359K | ﹤0.01% |
2,500
-300
| -11% | -$43.1K |
|
240
Guardant Health
GH
$7.5B
| $358K | ﹤0.01% |
+10,010
| New | +$358K |
|
241
Pacira BioSciences
PCRX
$1.19B
| $349K | ﹤0.01% |
8,705
-3,890
| -31% | -$156K |
|
242
PayPal
PYPL
$65.2B
| $315K | ﹤0.01% |
4,718
+442
| +10% | +$29.5K |
|
243
Pinduoduo
PDD
$177B
| $289K | ﹤0.01% |
+4,181
| New | +$289K |
|
244
Tandem Diabetes Care
TNDM
$850M
| $275K | ﹤0.01% |
11,210
| – | – |
|
245
KE Holdings
BEKE
$22.4B
| $264K | ﹤0.01% |
17,791
+1,189
| +7% | +$17.7K |
|
246
Omnicell
OMCL
$1.47B
| $263K | ﹤0.01% |
3,568
| – | – |
|
247
Standard BioTools
LAB
$497M
| $193K | ﹤0.01% |
100,000
| – | – |
|
248
Castle Biosciences
CSTL
$683M
| $184K | ﹤0.01% |
13,398
| – | – |
|
249
Stereotaxis
STXS
$264M
| $117K | ﹤0.01% |
76,687
| – | – |
|
250
Charles Schwab
SCHW
$167B
| – | – |
-61,102
| Closed | -$3.2M |
|